Back to Search
Start Over
172P A multi-center, randomized, double-blind, parallel, two-group phase III clinical study on the efficacy and safety of QL1101 or bevacizumab in combination with paclitaxel and carboplatin in the first-line treatment of non-squamous non-small cell lung cancer
- Source :
-
Annals of Oncology . 2019 Supplement, Vol. 30, pN.PAG-N.PAG. 1p. - Publication Year :
- 2019
- Subjects :
- *BEVACIZUMAB
*CARBOPLATIN
Subjects
Details
- Language :
- English
- ISSN :
- 09237534
- Volume :
- 30
- Database :
- Academic Search Index
- Journal :
- Annals of Oncology
- Publication Type :
- Academic Journal
- Accession number :
- 136076544
- Full Text :
- https://doi.org/10.1093/annonc/mdz063.070